Video
Author(s):
Michael Manns, MD, the Director of the Department of Gastroenterology, Hepatology and Endocrinology at the Medical School of Hannover in Germany, explains risk factors for hepatitis C-related hepatocellular carcinoma.
Michael Manns, MD, the Director of the Department of Gastroenterology, Hepatology and Endocrinology at the Medical School of Hannover in Germany, explains risk factors for hepatitis C-related hepatocellular carcinoma.
Patients who have had hepatitis C or cirrhosis have a greater risk of developing HCC, said Manns. However, it is difficult to confirm if clearing the virus decreases risk of HCC because almost all patients diagnosed with hepatitis C or cirrhosis are treated for the viruses, leaving no control group to compare risk factors with.
New strategies for surveillance of HCC risk are needed, says Manns. These could include understanding the connections between age and having high-alpha one fetoprotein and HCC.
Dr Grisham on the Efficacy of Avutometinib Plus Defactinib in Gynecologic Mesonephric Cancer
Dr Van Gorp on the Long-Term Efficacy of Mirvetuximab Soravtansine in FRα+ Platinum-Resistant Ovarian Cancer
Zimberelimab Plus Lenvatinib Shows Activity in ICI-Pretreated Advanced Cervical Cancer
Afuresertib Plus Paclitaxel Does Not Elicit Substantial Clinical Benefit in Platinum-Resistant Ovarian Cancer
2 Commerce Drive
Cranbury, NJ 08512